Serial #79407786
LIVE

Serial Number

79407786

Owner

Sandoz AG

Attorney

Maury M. Tepper, III

Filing Date

Jul 24, 2024

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79407786 Trademark

Serial Number: 79407786 • Registration: 7989014

Serial #79407786 is a trademark filed by Sandoz AG on July 24, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Sandoz AG (3 trademarks)

Viaduktstrasse 3

Entity Type: 03

Trademark Details

Filing Date

July 24, 2024

Registration Date

October 21, 2025

Published for Opposition

September 2, 2025

Goods & Services

Anti-infectives for human use; anti-inflammatories for human use; antibacterial pharmaceutical preparations for human use; antibiotics for human use; antifungal preparations for human use; antivirals for human use; cardiovascular pharmaceutical preparations for human use; dermatological pharmaceutical preparations for human use; pharmaceutical preparations for human use for inhaling for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations for human use acting on the central nervous system; pharmaceutical preparations and substances for human use for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for human use for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for human use, used in hematology and in tissue and organ transplantation; pharmaceutical preparations for human use for the prevention and treatment of eye diseases; pharmaceutical preparations for human use for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for human use for the prevention and treatment of diseases and disorders related to the immune system; pharmaceutical preparations for human use for the prevention and treatment of kidney diseases; pharmaceutical preparations for human use for the prevention and treatment of diabetes; pharmaceutical preparations for human use for the prevention and treatment of hypertension; pharmaceutical preparations for human use for the prevention and treatment of skin conditions; pharmaceutical preparations for human use, used in dermatology; pharmaceutical preparations for human use, used in urology; pharmaceutical preparations for human use, used in ophthalmology; pharmaceutical preparations for human use for the prevention and treatment of cancer and tumors; pharmaceutical preparations for human use for the prevention and treatment of allergies; pharmaceutical preparations for human use for the prevention and treatment of bone diseases; pharmaceutical preparations for human use for the prevention and treatment of respiratory diseases and asthma

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
May 14, 2026 FINV
FINAL DISPOSITION NOTICE SENT TO IB
Apr 30, 2026 FICS
FINAL DISPOSITION PROCESSED
Apr 30, 2026 FIMP
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Apr 9, 2026 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 23, 2026 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Mar 23, 2026 OPNR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 21, 2026 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Oct 21, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Oct 21, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 2, 2025 NPUB
PUBLISHED FOR OPPOSITION
Sep 2, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 27, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 31, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 30, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 30, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 30, 2025 TROA
REFUSAL PROCESSED BY IB
Mar 29, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 10, 2025 RFCS
REFUSAL PROCESSED BY MPU
Mar 10, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 22, 2025 RFCR
NON-FINAL ACTION WRITTEN
Jan 21, 2025 CNRT
ASSIGNED TO EXAMINER
Jan 10, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 1, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 1, 2024 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Nov 1, 2024 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 24, 2024 REPR